ArticleJornal brasileiro de nefrologia
Potential benefits of converting from short daily high-flux hemodialysis to short daily online hemodiafiltration: a pilot study.
Article in Jornal brasileiro de nefrologia. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Innovation in daily hemodialysis: high-flux vs. hemodiafiltration.Jornal brasileiro de nefrologiaArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionHigh-volume, conventional thrice-weekly hemodiafiltration appears to provide better outcomes than conventional hemodialysis. We aimed to evaluate whether the benefits of performing hemodiafiltration can be combined with those of frequent hemodialysis.
methodsThis was a single-center, longitudinal, A1-B-A2 design study that compared high-flux short daily hemodialysis (SDHD) with post-dilution online short daily hemodiafiltration (SDHDF).
resultsTwelve patients completed the study. Myoglobin clearance was greater during SDHDF (45.95 ± 11.0 mL/min) than during SDHD1 (20.11 ± 5.2 mL/min, P < 0.01) and SDHD2 (21.39 ± 3.55 mL/min, P < 0.01). A slightly higher pre-dialysis mean arterial pressure was observed during SDHDF (102.51 ± 11.28 mmHg) compared with SDHD1 (95.5 ± 9.82 mmHg, P < 0.01) and SDHD2 (97.61 ± 11.19 mmHg, P = 0.03). We also detected an increase in pre-dialysis hemoglobin during SDHDF (12.39 ± 1.2 g/dL) compared to SDHD1 (11.30 ± 1.09 g/dL, P = 0.02) and SDHD2 (11.23 ± 1.84 g/dL, P < 0.01). HDL-cholesterol was significantly higher at the end of the SDHDF period (52.75 ± 15.8 mg/dL) compared to SDHD1 (47.00 ± 10.8 mg/dL, P = 0.01) and SDHD2 (43.75 ± 11.1 mg/dL, P < 0.01) periods.
conclusionThe effect of converting SDHD to SDHDF was slightly positive in our study. In the long term, short daily hemodiafiltration might have more benefits for the dialysis population. This can lead to the adoption of hemodiafiltration as the standard of care even in the frequent hemodialysis setting.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.